131 related articles for article (PubMed ID: 23963235)
1. Defective HIV-1 quasispecies in the form of multiply drug-resistant proviral DNA within cells can be rescued by superinfection with different subtype variants of HIV-1 and by HIV-2 and SIV.
Quan Y; Xu H; Wainberg MA
J Antimicrob Chemother; 2014 Jan; 69(1):21-7. PubMed ID: 23963235
[TBL] [Abstract][Full Text] [Related]
2. Multidrug-resistant variants of HIV type 1 (HIV-1) can exist in cells as defective quasispecies and be rescued by superinfection with other defective HIV-1 variants.
Quan Y; Liang C; Brenner BG; Wainberg MA
J Infect Dis; 2009 Nov; 200(9):1479-83. PubMed ID: 19758098
[TBL] [Abstract][Full Text] [Related]
3. Cell surface CD4 downregulation and resistance to superinfection induced by a defective provirus of HIV-1.
Little SJ; Riggs NL; Chowers MY; Fitch NJ; Richman DD; Spina CA; Guatelli JC
Virology; 1994 Dec; 205(2):578-82. PubMed ID: 7975260
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms associated with the generation of biologically active human immunodeficiency virus type 1 particles from defective proviruses.
Inoue M; Hoxie JA; Reddy MV; Srinivasan A; Reddy EP
Proc Natl Acad Sci U S A; 1991 Mar; 88(6):2278-82. PubMed ID: 2006168
[TBL] [Abstract][Full Text] [Related]
5. Superinfection of defective human immunodeficiency virus type 1 with different subtypes of wild-type virus efficiently produces infectious variants with the initial viral phenotypes by complementation followed by recombination.
Iwabu Y; Mizuta H; Kawase M; Kameoka M; Goto T; Ikuta K
Microbes Infect; 2008 Apr; 10(5):504-13. PubMed ID: 18403230
[TBL] [Abstract][Full Text] [Related]
6. Recombination between human immunodeficiency viruses (HIV) type 1 and 2 results in generation of defective hybrid viruses.
Ranganathan PN; Srinivasan A
Biochem Biophys Res Commun; 1993 May; 193(1):311-7. PubMed ID: 8503921
[TBL] [Abstract][Full Text] [Related]
7. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis.
Aiken C; Trono D
J Virol; 1995 Aug; 69(8):5048-56. PubMed ID: 7541845
[TBL] [Abstract][Full Text] [Related]
8. Superinfection of human immunodeficiency virus type 1 (HIV-1) to cell clone persistently infected with defective virus induces production of highly cytopathogenic HIV-1.
Iwabu Y; Goto T; Tsuji S; Warachit J; Li GM; Shoji S; Kameoka M; Ikuta K
Microbes Infect; 2006 Jun; 8(7):1773-82. PubMed ID: 16815724
[TBL] [Abstract][Full Text] [Related]
9. The Landscape of Persistent Viral Genomes in ART-Treated SIV, SHIV, and HIV-2 Infections.
Bender AM; Simonetti FR; Kumar MR; Fray EJ; Bruner KM; Timmons AE; Tai KY; Jenike KM; Antar AAR; Liu PT; Ho YC; Raugi DN; Seydi M; Gottlieb GS; Okoye AA; Del Prete GQ; Picker LJ; Mankowski JL; Lifson JD; Siliciano JD; Laird GM; Barouch DH; Clements JE; Siliciano RF
Cell Host Microbe; 2019 Jul; 26(1):73-85.e4. PubMed ID: 31295427
[TBL] [Abstract][Full Text] [Related]
10. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses.
Shuh M; Hill SA; Derse D
Virology; 1999 Sep; 262(2):442-51. PubMed ID: 10502522
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 latency due to the site of proviral integration.
Winslow BJ; Pomerantz RJ; Bagasra O; Trono D
Virology; 1993 Oct; 196(2):849-54. PubMed ID: 8372452
[TBL] [Abstract][Full Text] [Related]
12. Interferon inhibits the replication of HIV-1, SIV, and SHIV chimeric viruses by distinct mechanisms.
Korth MJ; Taylor MD; Katze MG
Virology; 1998 Aug; 247(2):265-73. PubMed ID: 9705919
[TBL] [Abstract][Full Text] [Related]
13. Simian immunodeficiency virus vectors: replication and pseudotyping.
Rizvi TA; Panganiban AT
J Med Primatol; 1992; 21(2-3):69-73. PubMed ID: 1433269
[TBL] [Abstract][Full Text] [Related]
14. Early replication block of human immunodeficiency virus type 1 in monkey cells.
Shibata R; Sakai H; Kawamura M; Tokunaga K; Adachi A
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2723-30. PubMed ID: 7595379
[TBL] [Abstract][Full Text] [Related]
15. Human immunodeficiency virus (HIV) type 2-mediated inhibition of HIV type 1: a new approach to gene therapy of HIV-infection.
Arya SK; Gallo RC
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4486-91. PubMed ID: 8633095
[TBL] [Abstract][Full Text] [Related]
16. Multiple superinfections fail to activate defective human immunodeficiency virus-1 (HIV-1) infection of rabbits.
Sell S; Tseng CK
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):211-26. PubMed ID: 7788421
[TBL] [Abstract][Full Text] [Related]
17. Integrase of human endogenous retrovirus K-10 supports the replication of replication-incompetent Int- human immunodeficiency virus type 1 mutant.
Ogata T; Okui N; Sakuma R; Kobayashi N; Kitamura Y
Jpn J Infect Dis; 1999 Dec; 52(6):251-2. PubMed ID: 10738367
[No Abstract] [Full Text] [Related]
18. A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions.
Kulkosky J; BouHamdan M; Geist A; Pomerantz RJ
Virology; 1999 Mar; 255(1):77-85. PubMed ID: 10049823
[TBL] [Abstract][Full Text] [Related]
19. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques.
Ambrose Z; Boltz V; Palmer S; Coffin JM; Hughes SH; Kewalramani VN
J Virol; 2004 Dec; 78(24):13553-61. PubMed ID: 15564466
[TBL] [Abstract][Full Text] [Related]
20. Chimeric HIV-1 containing SIV matrix exhibit enhanced assembly in murine cells and replicate in a cell-type-dependent manner in human T cells.
Chen P; Hübner W; Riviere K; Liu YX; Chen BK
Virology; 2006 May; 349(1):1-12. PubMed ID: 16563454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
